loading page

A case of heparin induced thrombocytopenia managed by Rivaroxaban
  • Ali Eshraghi,
  • Faeze Keihanian
Ali Eshraghi
Mashhad University of Medical Sciences

Corresponding Author:[email protected]

Author Profile
Faeze Keihanian
Mashhad University of Medical Sciences
Author Profile

Abstract

Heparin-induced thrombocytopenia (HIT) is an immunogenic disorder. It can lead to thrombocytopenia and a hypercoagulated state with an increased risk for new thrombosis. We here reported a 49-year-old man with previous cardiac surgery and heparin administration, treated by new oral anticoagulant agent, Rivaroxaban.